Related Experiment Video
Updated: Jun 28, 2026

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
Adipocytokines and liver disease
Yoshihiro Kamada1, Tetsuo Takehara, Norio Hayashi
1Department of Gastroenterology and Hepatology, Osaka University, Graduate School of Medicine, 2-2 K1 Yamadaoka, Suita, Osaka 565-0871, Japan.
Obesity causes chronic inflammation and adipocytokine dysregulation, increasing metabolic syndrome and liver disease risk. This review explores adipocytokines like leptin and adiponectin
Area of Science:
- Endocrinology and Metabolism
- Immunology
- Hepatology
Background:
- Obesity is characterized by chronic low-grade inflammation originating from adipose tissue.
- Hypertrophied adipocytes release chemokines, recruiting macrophages that produce pro-inflammatory cytokines and nitric oxide.
- This inflammatory milieu leads to adipocytokine dysregulation, with decreased anti-inflammatory and increased pro-inflammatory factors.
Purpose of the Study:
- To review the role of adipocytokines in obesity-related metabolic disorders and chronic liver diseases.
- To discuss the association between specific adipocytokines (leptin, adiponectin, TNF-alpha, resistin) and liver pathology.
Main Methods:
- Literature review of recent advances in medical research.
- Analysis of the relationship between adipocytokine profiles and metabolic syndrome components.
- Examination of the link between adipocytokine dysregulation and various chronic liver diseases.
Main Results:
- Adipocytokine dysregulation is a key feature of obesity, contributing to metabolic syndrome (diabetes, hypertension, hyperlipidemia, NASH).
- Obesity is an independent risk factor for chronic liver diseases, including nonalcoholic steatohepatitis (NASH), alcoholic liver disease, hepatitis C, and hepatocellular carcinoma.
- Adipocytokine dysregulation is implicated as a common underlying mechanism in these hepatic conditions.
Conclusions:
- Adipocytokine dysregulation plays a critical role in the pathogenesis of metabolic syndrome and obesity-related liver diseases.
- Understanding the specific roles of leptin, adiponectin, TNF-alpha, and resistin is crucial for developing therapeutic strategies.
- Targeting adipocytokine pathways may offer novel approaches for managing metabolic and hepatic complications of obesity.
More Related Videos
07:46Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
10:40Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro
Published on: December 5, 2025
Related Concept Videos
Chronic Pancreatitis II: Pathophysiology
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Acute Pancreatitis II: Pathophysiology
Cirrhosis II: Pathophysiology
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...